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Human fibroblasts were labelled with either [35S]methionine or t3H]palmitate and analyzed for the presence 
of 35S- or 3H-labelled fibronectin by immunoprecipitation and SDS-polyacrylamide gel electrophoresis. The 
majority of 3sS-labelled fibronectin was found in the extracellular matrix of cells which could be removed 
quantitatively by mild trypsin treatment. In contrast, 3H-labelled fibronectin was found in a trypsin-resistant 
form. The 3H label of fibronectin could be identified predominantly as [3H]palmitate by HLPC analysis. 
The fatty acids remained stably associated with fibronectin during extraction and electrophoresis, indicating 
a covalent linkage. These results demonstrate that a subset of fibronectin different from extracellular matrix 
fibronectin is modified by acylation. 
Fibronectin Posttranslational modification 
1. INTRODUCTION 
Fibronectin is a high44r glycoprotein present in 
closely related forms in the plasma of vertebrates, 
in the extracellular matrix, on cell surfaces and in- 
tracellular in a perinuclear distribution [l]. It has 
been implicated in a variety of biological func- 
tions, most of which involve cell-to-cell and cell-to- 
cell-matrix interactions, cell shape formation and 
cellular migration [2]. Some of these activities im- 
plicate interactions of cell surface associated 
fibronectin with intracellular cytoskeletal elements 
[2]. The molecular basis of a transmembrane link 
between fibronectin and the cytoskeleton is not 
understood. A direct insertion of fibronectin in 
plasma membranes eems to be unlikely since the 
cell attachment domain of fibronectin is rich in 
hydrophilic amino acids [3]. Alternatively, the in- 
teractions of fibronectin with the intracellular 
cytoskeleton might be mediated by membrane 
receptors for fibronectin. Although gangliosides 
[4], phospholipids [5], glycoproteins [6] and 
heparan sulfate proteoglycans [7] may play a role 
in the attachment of fibronectin with plasma mem- 
Protein acylation Extracellular matrix 
branes, a fibronectin receptor could not be iden- 
tified as yet. During the past few years several pro- 
teins have been found to be posttranslationally 
modified by a covalent linkage to fatty acids [8]. 
The acylation of proteins is thought to anchor 
otherwise soluble proteins in membranes [9, lo]. 
Therefore, I analyzed cellular fibronectin for the 
presence of covalent bound fatty acids. 
Here, I describe that a subset of fibronectin is 
specifically modified by covalent attachment to 
palmitic acid and can be distinguished from ex- 
tracellular matrix associated fibronectin on the 
basis of its resistance against trypsin treatment. 
These results may indicate that acylation of 
fibronectin mediates a tight attachment of 
fibronectin with plasma membranes. 
2. MATERIALS AND METHODS 
2.1. Radiolabelling and extraction of cells 
2.5 x lo6 Ge 38 cells (a human fibroblast cell 
line) grown in petri dishes in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% 
fetal calf serum, were labelled for 4 h with either 
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100 ,di [35S]methionine (NEN) in 10 ml 
methionine-free DMEM supplemented with 0.1% 
bovine serum albumin or with 5 mCi [3H]palmitate 
(NEN) in 10 ml DMEM supplemented with 10% 
tryptose phosphate broth, 2.5% fetal calf serum 
and 5 mM sodium pyruvate. After washing 3 times 
with PBS the cells were incubated for 30 min at 
room temperature with extraction buffer [50 mM 
Tris (pH 7.0), 25 mM KCI, 5 mM MgC12, 5 mM 
DTT, 1 mM EGTA, 1% Empigen BB (Albright 
and Wilson, Frankfurt), 1% NP40 and 10% 
TrasylolR (Bayer, FRG)]. Cell extracts were 
sonified and clarified by centrifugation for 30 min 
at 106000 x g. 
2.2. Immunoprecipitation and gel electrophoresis 
Cell extracts were immunoprecipitated with an- 
tibodies against fibronectin [antibody 1, rabbit 
anti-human plasma fibronectin (Behring); an- 
tibody 2, rabbit anti-bovine plasma fibronectin 
(Calbiochem); antibody 3, PHM 13 (Serotoc), a 
monoclonal antibody specifically binding to 
cellular fibronectin] and analyzed by SDS- 
polyacrylamide gel electrophoresis as in [l I]. Gels 
were stained with Coomassie brilliant blue R250 
and the total amount of fibronectin determined by 
scanning the gel with a Quick Scan R&D den- 
sitometer (Helena Laboratories) using purified 
plasma fibronectin as standard. For the evaluation 
of ‘H or 35S uptake in radiolabelled fibronectin, 
the fibronectin-containing areas of the gel were cut 
out of the gel, eluted and counted for radioactivity 
as in [ 111. To determine the radioactive 
background, gel slices of equal size above and 
below the fibronectin-containing area were ana- 
lyzed for radioactivity in parallel. The results are 
given as the 3H cpm from the fibronectin area 
minus the 3H cpm determined as background. 
2.3. HPLC analysis of lipids 
Lipids from [3H]palmitate-labelled fibronectin 
purified by immunoprecipitation were extracted 
with 2 N HCl in 82% methanol for 5 h at 70°C 
and dried in vacua, followed by treatment with 0.5 
KOH in methanol for 1 h at 40°C. After extraction 
of lipid in acetone, a mixture of appropriate lipid 
standards was added, and the fatty acids deriva- 
tized with 4-Br-phenacyl bromide according to 
[ 121. Samples were subjected to a 27 x 4 cm HPLC 
column on Shandon ODS hypersil (5 pm) using 
methanol as eluant. Fractions were collected every 
10 s and the absorbance profile of the phenacyl 
esters identified spectrometrically. Radioactively 
labelled phenacyl esters of fatty acids were 
detected by scintillation counting. 
Since it is known that up to 50% of the 3H label 
in [3H]palmitate-labelled cells were metabolically 
converted into amino acids which subsequently 
were incorporated into the polypeptide backbone 
of proteins [13], the ‘H label in fibronectin was 
analyzed by HPLC as described in section 2.3. As 
shown in fig.2, approximately one half of the ‘H 
label in fibronectin could be recovered as the 
phenazyl esters of [3H]palmitic acid, whereas the 
other half of the label purified in the front peak of 
HPLC. Short fatty acids should evaporate under 
our conditions (drying of samples in vacua), 
whereas hydrophobic amino acids are soluble in 
the organic phase. Therefore, we suppose that the 
front peak in our HPLC experiments comprises 
radioactively labelled hydrophobic amino acids 
rather than short fatty acids. These results clearly 
demonstrate that fibronectin is in fact bound to 
palmitic acid. Several criteria indicate a covalent 
linkage between fibronectin and fatty acids: 
(0 
(ii) 
(iii) 
(iv) 
Fatty acids remained associated with fibronec- 
tin during extraction with ionic and nonionic 
detergents (Empigen BB, NP40, see section 
2.1). 
The fatty acids could not be removed from 
fibronectin by boiling in 3% SDS for 5 min. 
The fatty acids were still bound to fibronectin 
after SDS-polyacrylamide gel electrophoresis. 
Fatty acids could only be quantitatively 
cleaved from fibronectin by acid hydrolysis 
(see section 2.3). 
3. RESULTS AND DISCUSSION 
Fibronectin in extracts of [3H]palmitate-labelled 
human Ge 38 cells was immunoprecipitated with 
different polyclonal anti-fibronectin antibodies 
(antibodies 1 and 2) and a monoclonal anti- 
fibronectin antibody (antibody 3) and analyzed on 
5% SDS-polyacrylamide gels as shown in fig.1. 
Fibronectin immunoprecipitated by all of the three 
antibodies used was 3H-labelled. 
Most of the acylated proteins, especially those 
bound to palmitic acid, are glycosylated intrinsic 
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Fig. 1. Detection of [3H]palmitate-labelled flbronectm in human fibroblasts. [3H]Palmitate-labelled Ge 38 fibroblasts 
were lysed and immunoprecipitated with antibodies to human (antibody 1) or bovine plasma fibronectin (antibody 2) 
or a monoclonal antibody (antibody 3). Immunoprecipitates were run on 5% SDS-polyacrylamide slab gels and stained 
with Coomassie blue (left). As a standard, purified human fibronectin (5, 10 and 20pg) was run on the same gel. 
Fibronectin was quantitated densitometrically, eluted and counted for incorporated 3H label (right). The results 
represent he specific label of fibronectin (see section 2.2). 
membrane proteins [8,13]. In contrast, cellular were labelled either with [35S]methionine or 
fibronectin is localized predominantly in the ex- [3H]palmitate in parallel. Half of the cells were 
tracellular matrix, at the plasma membrane and in treated in situ with trypsin as described above in 
small amounts in the cytoplasm as the newly syn- order to remove extracellular fibronectin. 
thesized precursor of cellular fibronectin [2,14]. Fibronectin from trypsin-treated and untreated 
Extracellular matrix associated fibronectin can be cells was purified by immunoprecipitation and 
quantitatively removed by mild trypsin treatment, SDS-polyacrylamide gel electrophoresis. The label 
whereas plasma membrane fibronectin and the in- incorporated in fibronectin was quantitatively 
tracellular precursor of cellular fibronectin are determined as described for fig.1. The majority 
protected [14]. In accordance with the data of (up to 70%) of total cellular fibronectin as well as 
Yamada [14] I could quantitatively remove ex- [35S]methionine-labelled fibronectin could be 
tracellular matrix associated ’ fibronectin by digested by trypsin treatment, whereas 
treating living monolayer cells with 5000 units [3H]palmitate-labelled fibronectin was resistant o 
trypsin/l x lo6 Ge 38 cells for 10 min’ at room trypsin treatment under our labelling conditions 
temperature, as judged by immunofluorescence (fig.3). Together with the immunofluorescence 
microscopy (not shown). For the determination of data one can conclude that approx. 70% of the 
the localization of acylated fibronectin Ge 38 cells total cellular fibronectin as well as fibronectin syn- 
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Fig.2. HPLC analysis of [3H]palmitate-labelled fibro- 
nectin. Ge 38 cells were labelled with [3H]palmitate, 
extracted and immunoprecipitated using antibody 1. 
Fatty acids bound to immunoprecipitates of fibronectin 
were released by acid hydrolysis and subjected to HPLC 
analysis as described in section 2.3. The positions of the 
non-labelled internal lipid standards are indicated. 
thesized during the 4 h labelling period is localized 
in the extracellular matrix. In contrast, acylated 
fibronectin could not be digested by trypsin treat- 
ment, indicating that this subset of cellular 
fibronectin is predominantly attached with the 
plasma membrane as described for nearly all 
palmitoylated proteins [ 131. 
Although the role of posttranslational modifica- 
tions of proteins with long-chain fatty acids re- 
mains to be determined, studies of transforming 
35 S-methionine 
labelled FN 
(c.p.m. 1 
3H-palmitic acid 
labelled FN 
(c.p.m. 1 
Fig.3. Comparison of the trypsin sensitivity of total fibronectin, [35S]methionine-labelled fibronectin and [3H]palmitate- 
labelled fibronectin. Ge 38 cells were labelled with either [‘Hlpalmitate or [35S]methionine and treated with trypsin (5000 
units/l x lo6 cel!s for 10 min at room temperature). Cells were extracted and immunoprecipitated with antibody 2. 
Fibronectin from trypsin-treated cells or cells treated with PBS as control was purified on SDS-polyacrylamide slab gels. 
The determination of total fibronectin @g) or radioactively labelled fibronectin 3H cpm or “S cpm was carried out as 
described in f&l. 
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proteins of viruses [9,10,15] as well as of cellular 
proteins which are involved in the regulation of cell 
growth [16,17] indicate that the binding of proteins 
to palmitic acid may stabilize the attachment of 
proteins with the plasma membrane. Since 
fibronectin performs most of its functions by in- 
teractions with cell surfaces, the study of acylated 
fibronectin and its possible interactions with 
plasma membranes and/or components of the 
cytoskeleton might help in understanding the 
multiple functions of this major cellular protein on 
the regulation of cell shape, cell growth and cell 
mobility at the molecular level. 
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